Pharmaceuticals Market Research Reports & Industry Analysis
Pharmaceuticals Industry Research & Market Reports
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
Mental Health & Substance Abuse Services
... include Acadia Healthcare, Hazelden Betty Ford Foundation, and Spectrum Health Systems (all based in the US), along with the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). COMPETITIVE LANDSCAPE Demand for ... Read More
-
Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024
... projected to cross US$ 5 Billion by 2024. Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The use of illicit drugs ... Read More
-
Commercial Interest at ESMO Annual Meeting 2018: Analytical Tool
... from the European Society of Medical Oncology (ESMO 2017) congress. Similar in scope to it's American cousin ASCO, this conference features more than 2000 abstracts detailing the latest ground-breaking science and in this too we ... Read More
-
Global Multivitamin and Mineral Supplements Market 2018-2022
... to overcome the deficiency of vitamins and minerals in the regular diet. Technavio’s analysts forecast the Global Multivitamin and Mineral Supplements Market to grow at a CAGR of 4.60% during the period 2018-2022. Covered in ... Read More
-
Global Sjogren’s Syndrome Therapeutics Market 2018-2022
... and moisture-secreting glands in the mouth secrete smaller amounts of saliva. Technavio’s analysts forecast the Global Sjogren’s Syndrome Therapeutics Market to grow at a CAGR of 4.12% during the period 2018-2022. Covered in this report ... Read More
-
Panama Pharmaceuticals & Healthcare Q4 2018
... system inefficiencies will continueto weigh on the country’s ability to improve access to healthcare. Sustained pro-growth economic policies and the Panama Canalwill continue to support the country’s position as a logistic and export hub, including ... Read More
-
Ventricular Tachycardia - Pipeline Review, H2 2018
... landscape. Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and ... Read More
-
Namibia Pharmaceuticals & Healthcare Q4 2018
... and efficiency issues within the public healthcare sector. The small middle-and upper-class segments provide pockets of demand for innovative medicines, which will continue to be imported by key regionalplayers and representative offices of established multinationals. Read More
-
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2018
... 2018, provides an overview of the Vaso-Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline landscape. Vaso-occlusive crisis associated with sickle cell disease is a painful episode that occurs in people who have sickle cell ... Read More
-
Global Gastrointestinal Endoscopy Market: Industry Analysis & Outlook (2018-2022)
... their method of diagnosis and treatment a constantly evolving field. As such endoscopy emerges out as the gold standard for diagnosis of GI cancers. Early diagnosis of GI tumors by endoscopy at the precancerous or ... Read More
-
Zimbabwe Pharmaceuticals & Healthcare Q4 2018
... multinational drugmakers are deterred by thechallenging macroeconomic environment. Achieving self-sufficiency in the sector will require currency regime reform; however, itremains unclear which new regime they will adopt. This creates uncertain conditions in Zimbabwe's pharmaceutical market ... Read More
-
Poland Pharmaceuticals & Healthcare Q4 2018
... future of the Fund; however, the outlook for the pharmaceutical market andhealthcare sector remain positive. Continued state healthcare funding growth and consumer-led economic growth will provide aboost to market expenditure, maintaining the country's regional outperformance. Read More
-
Low Back Pain - Pipeline Review, H2 2018
... Pain (Central Nervous System) pipeline landscape. Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving ... Read More
-
Global Radiology Information Systems Market 2018-2022
... of patients. Technavio’s analysts forecast the Global Radiology Information Systems Market to grow at a CAGR of 1.33% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth ... Read More
-
Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022
... (fast-growing), complex, and difficult-to-treat form of NHL, which refers to a group of cancers of the lymphatic system. Technavio’s analysts forecast the Global DLBCL Therapeutics Market to grow at a CAGR of 7.64% during the ... Read More
-
Hypertrophic Cardiomyopathy - Pipeline Review, H2 2018
... landscape. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially ... Read More
-
Azerbaijan Pharmaceuticals & Healthcare Q4 2018
... pharmaceutical market, we remain cautious about its commercial attractiveness to multinationals, at least in theshort term. The over-reliance on out-of-pocket payments has made the market vulnerable to economic fluctuations, especiallygiven its reliance on imported medicines. Read More
-
Insomnia - Pipeline Review, H2 2018
... Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches and distress in the stomach and intestines. Risk ... Read More
-
Myanmar Pharmaceuticals & Healthcare Q4 2018
... underdeveloped state of the public health sector will shape commercialopportunities for private healthcare providers. Despite this, the upcoming rollout of universal healthcare coverage will improve long-term opportunities for investment in Myanmar’s pharmaceutical and healthcare sectors. Read More
-
Tunisia Pharmaceuticals & Healthcare Q4 2018
... will challenge foreign investment into the sector.Highlighting the market's longer-term potential, some multinational drugmakers have shown their willingness to do business in thecountry, though the majority choose to operate indirectly to minimise the risks involved. Read More
-
Venezuela Pharmaceuticals & Healthcare Q4 2018
... crisis in Venevzuela will continue to restrict healthcare spending, limiting public access to medicine andhealthcare services. Medicine shortages will persist with continued hyperinflation, the re-denomination of the Venezuelan bolívarand reduced drugmaker activities in the country. Read More
-
Guillain-Barre Syndrome - Pipeline Review, H2 2018
... System) pipeline landscape. Guillain-Barre syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of this disorder include varying degrees of weakness or tingling ... Read More
-
Binge Eating Disorder - Pipeline Review, H2 2018
... Disorder (Central Nervous System) pipeline landscape. Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting ... Read More
-
Rett Syndrome - Pipeline Review, H2 2018
... System) pipeline landscape. Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, ... Read More
